President Biden Tweets ‘Starting this week, the federal government will set up emergency testing sites in areas that need additional testing capacity. Before Christmas, the first several of these federal testing sites will be up and running in New York…
https://twitter.com/POTUS/status/1473402686955479041
New York Attorney General Issues Post ‘Attorney General James Issues Warning to LabQ Diagnostics to Stop Misrepresenting Turnaround Times for COVID-19 Test Results’
https://ag.ny.gov/press-release/2021/attorney-general-james-issues-warning-labq-diagnostics-stop-misrepresenting
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
Here's a roundup of top developments in the biotech space over the last 24 hours:
‘Senate votes to repeal key Biden administration vaccine and testing policy’ -Earlier Washington Post Report
https://www.washingtonpost.com/us-policy/2021/12/08/republicans-vaccine-congress-coronavirus/
White House Chief Of Staff Ronald Klain Says President Biden Will Announce Today ‘FREE and RELIABLE’ COVID At Home Tests
https://twitter.com/WHCOS/status/1466404937525567496?s=20
‘Stricter coronavirus testing to be required for all travelers to the U.S. amid omicron variant concerns’ -Washington Post Report
https://www.washingtonpost.com/health/2021/11/30/omicron-stricter-travel-rules-us-entry/
Qiagen, Becton Dickinson Settle Patent Infringement Lawsuit For $53M
Qiagen N.V. (NYSE:QGEN) settled with Becton Dickinson & Co (NYSE:BDX) a patent infringement lawsuit related to Qiagen’s NeuMoDx 96 and NeuMoDx 288 clinical…